Welcome to
On Feet Nation
Robert Online
Amy Online
Lovina Lindy Online
Thomas Shaw Online
olismith Online
Terry Online
Posted by Lovina Lindy on August 14, 2024 at 10:16pm 0 Comments 0 Likes
Posted by Lovina Lindy on August 14, 2024 at 10:13pm 0 Comments 0 Likes
Global Erythropoietin Drugs Market Size, Share, Growth, Industry Trends and Forecast 2020-2030
Erythropoietin is a glycoprotein hormone released by the human renal system. This hormone helps in the production of red blood cells that carry oxygen from the lungs to the various parts of the body. Erythropoietin drugs control the process of erythropoiesis, i.e. the production of red blood cells. These drugs are mainly used in the treatment of chemotherapy-induced anaemia, cancer, and HIV. The growing population across the globe along with increasing HIV, cancer, and chronic renal diseases is the major factor driving the erythropoietin drugs market worldwide. The global erythropoietin drugs market is accounted approximate USD 8.9 billion in 2020 and it is expected to reach approximate USD 27.8 million by 2030 with a CAGR of 12.1% during forecast period.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020189
Market Dynamics and Factors:
The increasing number of patients suffering from anaemic conditions due to HIV, cancer, and end-stage renal diseases (ESRD), favourable reimbursements, and the rapid commercialisation of erythropoietin drugs are the major factors driving the growth of the erythropoietin drugs market. For instance, according to Centres for Disease Control and Prevention (CDC), around 5.5 million ambulatory care patients suffer from anaemia due to nutritional deficiency, while chronic disease is the second most dominant cause. The surge in drug patent expiration has increased the emphasis on the usage of biosimilar medicines having the same therapeutic effect with lower cost. This is another key factor that will fuel the growth of the erythropoietin drugs market in the coming future. Other major factors driving the global erythropoietin drugs market include inactive lifestyles attributing to deficiencies in iron, vitamin B12, and folic acid resulting in anaemic conditions; increase in blood transfusion during surgeries and treatments; and rising geriatric population. However, high costs of erythropoietin drugs and longer duration of treatments are some restraining factors that may hinder the growth of the market to some extent.
Market Segmentation:
Global Erythropoietin Drugs Market – By Drug Class
Biologics
Biosimilar
Global Erythropoietin Drugs Market – By Product
Epoetin-Alfa
Epoetin-Beta
Darbepoetin-Alfa
Others
Global Erythropoietin Drugs Market – By Application
Cancer
Haematology
Renal Diseases
Neurology
Global Erythropoietin Drugs Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020189
Geographic Analysis:
North America is expected to be the most dominant region for erythropoietin drugs in terms of revenue market share during the forecast period. Growing incidences of chronic kidney diseases (CDK), cancer, and HIV; presence of excellent healthcare facilities; and increasing investments in novel drug discoveries are some of the major factors responsible for the market dominance of the North American region. For instance, in the U.S, around 20 million people suffer from chronic kidney diseases out of which 2-4 million are having anaemia. The presence of major erythropoietin drug manufacturers in North America further enhances the growth of the market in the region. The existence of a significant amount of geriatric population in the European region has made it the second most dominant market for erythropoietin drugs. The Asia Pacific region is anticipated to be the fastest growing market for erythropoietin drugs during the forecast period. The rapid development in healthcare infrastructure, enhanced purchasing power, rising medical tourism are certain factors attributing towards the market growth in the APAC region. Rising prevalence of chronic diseases in the APAC region presents a lucrative opportunity for biosimilars with low cost of therapy in the region.
Competitive Scenario:
The key players operating in the global erythropoietin drugs market are –
Johnson & Johnson, Roche Holding AG, Biocon Limited, Celltrion Inc., LG Life Sciences Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Amgen Inc., Teva Pharmaceutical Industries Ltd.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020189
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Erythropoietin Drugs industry, although key threats, opportunities and disruptive technologies that could shape the Global Erythropoietin Drugs Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Erythropoietin Drugs Market most.
The data analysis present in the Global Erythropoietin Drugs Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Erythropoietin Drugs Market business.
The 2021 Annual Global Erythropoietin Drugs Market offers:
100+ charts exploring and analysing the Global Erythropoietin Drugs Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Erythropoietin Drugs Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020189
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation